文献类型： 会议论文

第一作者： Erika Berqer

作者： Erika Berqer ¹ ; Chad Johannes ² ; Gerald Post ³ ; Gillian Rothchild ⁴ ; Kai-Biu Shiu ⁵ ; Sarah Wetzel ⁶ ; Chelsea Tripp ⁷ ; Theresa Arteaga ⁸ ; Martin Crawford-Jukubiak ⁹ ; Anna Rita Serras ¹⁰ ;

作者机构： 1.lowa State University College of Veterinary Medicine, Ames, I A, USA

2.The Veterinary Cancer Center, Norwalk, CT, USA

3.Veterinary Specialty Center, Madison, Wl, USA

4.Veterinary Cancer Specialty Center, Seattle, WA, USA

5.Animal Cancer Center, Monterey, CA, USA

6.Sage Centers for Veterinary Specialty and Emergency Care, Concord, CA, USA

7.Animal Health Trust, Newmarket, Suffolk, UK

8.Summit Veterinary Referral Center, Tacoma, WA, USA

9.Blue Pearl Specialty and Emergency Medicine for Pets, Grand Rapids, Ml, USA

10.lowa Veterinary Specialties, Des Moines, IA, USA

会议名称： Conference of the American College of Veterinary Internal Medicine

主办单位：

页码： 46-

摘要： The purpose of this study was to solicit and compile data from practicing veterinary specialists regarding their use of toceranib in cats with mast cell neoplasia and to provide initial assessment of possible clinical benefit and toxicity.The American College of Veterinary Internal Medicine Oncology and Small Animal Internal Medicine listserves were used to solicit data pertaining to cases in which toceranib was used in the treatment of feline mast cell neoplasia. Cases were included if the following data were received: signalment (age, gender, breed), anatomic classification of disease (cutaneous or visceral), previous and concurrent treatment, toceranib dose (mg/kg) and schedule, duration of therapy, best response, and documentation of adverse events.

分类号： S85-532